rivastigmine tartrate

Generic: rivastigmine tartrate

Labeler: sun pharmaceutical industries, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivastigmine tartrate
Generic Name rivastigmine tartrate
Labeler sun pharmaceutical industries, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

rivastigmine tartrate 1.5 mg/1

Manufacturer
Sun Pharmaceutical Industries, Inc.

Identifiers & Regulatory

Product NDC 62756-145
Product ID 62756-145_a905f5ce-ae1b-4511-acd3-62883a3e3546
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077131
Listing Expiration 2026-12-31
Marketing Start 2010-07-01

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62756145
Hyphenated Format 62756-145

Supplemental Identifiers

RxCUI
312835 312836 314214 314215
UPC
0362756145863 0362756147867 0362756146860 0362756148864
UNII
9IY2357JPE

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivastigmine tartrate (source: ndc)
Generic Name rivastigmine tartrate (source: ndc)
Application Number ANDA077131 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1.5 mg/1
source: ndc
Packaging
  • 500 CAPSULE in 1 BOTTLE (62756-145-13)
  • 100 BLISTER PACK in 1 BOX, UNIT-DOSE (62756-145-61) / 1 CAPSULE in 1 BLISTER PACK
  • 60 CAPSULE in 1 BOTTLE (62756-145-86)
source: ndc

Packages (3)

62756-145-13 500 CAPSULE in 1 BOTTLE (62756-145-13) 62756-145-61 100 BLISTER PACK in 1 BOX, UNIT-DOSE (62756-145-61) / 1 CAPSULE in 1 BLISTER PACK 62756-145-86 60 CAPSULE in 1 BOTTLE (62756-145-86)

Ingredients (1)

rivastigmine tartrate (1.5 mg/1)

Linked Drug Pages (1)

Rivastigmine Tartrate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a905f5ce-ae1b-4511-acd3-62883a3e3546", "openfda": {"upc": ["0362756145863", "0362756147867", "0362756146860", "0362756148864"], "unii": ["9IY2357JPE"], "rxcui": ["312835", "312836", "314214", "314215"], "spl_set_id": ["bac9ca81-db70-41aa-82af-6c5bb8496846"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE in 1 BOTTLE (62756-145-13)", "package_ndc": "62756-145-13", "marketing_start_date": "20100701"}, {"sample": false, "description": "100 BLISTER PACK in 1 BOX, UNIT-DOSE (62756-145-61)  / 1 CAPSULE in 1 BLISTER PACK", "package_ndc": "62756-145-61", "marketing_start_date": "20100701"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (62756-145-86)", "package_ndc": "62756-145-86", "marketing_start_date": "20100701"}], "brand_name": "Rivastigmine Tartrate", "product_id": "62756-145_a905f5ce-ae1b-4511-acd3-62883a3e3546", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "62756-145", "generic_name": "Rivastigmine Tartrate", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine Tartrate", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "1.5 mg/1"}], "application_number": "ANDA077131", "marketing_category": "ANDA", "marketing_start_date": "20100701", "listing_expiration_date": "20261231"}